MedPath

Candesartan

Generic Name
Candesartan
Brand Names
Atacand, Atacand Hct
Drug Type
Small Molecule
Chemical Formula
C24H20N6O3
CAS Number
139481-59-7
Unique Ingredient Identifier
S8Q36MD2XX

Overview

Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is available as a prodrug in the form of candesartan cilexetil.

Background

Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is available as a prodrug in the form of candesartan cilexetil.

Indication

May be used as a first line agent to treat uncomplicated hypertension, isolated systolic hypertension and left ventricular hypertrophy. May be used as a first line agent to delay progression of diabetic nephropathy. Candesartan may be also used as a second line agent in the treatment of congestive heart failure, systolic dysfunction, myocardial infarction and coronary artery disease in those intolerant of ACE inhibitors.

Associated Conditions

  • Hypertension
  • NYHA Functional Class II-IV Heart Failure

FDA Approved Products

candesartan cilexetil and hydrochlorothiazide
Manufacturer:Zydus Pharmaceuticals USA Inc.
Route:ORAL
Strength:16 mg in 1 1
Approved: 2022/11/08
NDC:68382-194
Candesartan Cilexetil and Hydrochlorothiazide
Manufacturer:Mylan Pharmaceuticals Inc.
Route:ORAL
Strength:32 mg in 1 1
Approved: 2020/08/15
NDC:0378-3003
Candesartan Cilexetil and Hydrochlorothiazide
Manufacturer:Macleods Pharmaceuticals Limited
Route:ORAL
Strength:16 mg in 1 1
Approved: 2022/10/17
NDC:33342-131
CANDESARTAN CILEXETIL
Manufacturer:Alembic Pharmaceuticals Inc.
Route:ORAL
Strength:8 mg in 1 1
Approved: 2021/09/30
NDC:62332-342
Candesartan cilexetil
Manufacturer:Golden State Medical Supply, Inc.
Route:ORAL
Strength:8 mg in 1 1
Approved: 2024/04/05
NDC:51407-883

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath